Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2
Phase 1
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000316
- Locations
- ๐บ๐ธ
Johns Hopkins University, Baltimore, Maryland, United States
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000345
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Alternate-Day Buprenorphine Administration. Phase II - 4
Phase 1
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000222
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
Phase 1
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000355
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
Not Applicable
Terminated
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 16
- Registration Number
- NCT00000243
- Locations
- ๐บ๐ธ
Johns Hopkins University (BPRU) Bayview Campus, Baltimore, Maryland, United States
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Phase 2
Terminated
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000310
- Locations
- ๐บ๐ธ
Brown University School of Medicine, Providence, Rhode Island, United States
Comparison of Buprenorphine and Methadone - 3
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000334
- Locations
- ๐บ๐ธ
Washington DC VA, Washington, District of Columbia, United States
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
Phase 3
Completed
- Conditions
- Heroin Dependence
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-11-07
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000302
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Buprenorphine Detox With Two Types of Treatment. BBD I - 10
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-08-17
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000228
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Methadone/Buprenorphine Cross-Over Study - 4
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-08-17
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000208
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath